These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 20353374

  • 1. Posttransplant soluble CD30 as a predictor of acute renal allograft rejection.
    Kamali K, Abbasi MA, Farokhi B, Abbasi A, Fallah P, Seifee MH, Ghadimi N, Rezaie AR.
    Exp Clin Transplant; 2009 Dec; 7(4):237-40. PubMed ID: 20353374
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of posttransplantation soluble CD30 for diagnosis of acute renal allograft rejection.
    Pelzl S, Opelz G, Daniel V, Wiesel M, Süsal C.
    Transplantation; 2003 Feb 15; 75(3):421-3. PubMed ID: 12589170
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serial soluble CD30 measurements as a predictor of kidney graft outcome.
    Halim MA, Al-Otaibi T, Al-Muzairai I, Mansour M, Tawab KA, Awadain WH, Balaha MA, Said T, Nair P, Nampoory MR.
    Transplant Proc; 2010 Apr 15; 42(3):801-3. PubMed ID: 20430176
    [Abstract] [Full Text] [Related]

  • 7. Plasma levels of soluble CD30 in kidney graft recipients as predictors of acute allograft rejection.
    Ayed K, Abdallah TB, Bardi R, Abderrahim E, Kheder A.
    Transplant Proc; 2006 Sep 15; 38(7):2300-2. PubMed ID: 16980071
    [Abstract] [Full Text] [Related]

  • 8. Pre- and post-transplant monitoring of soluble CD30 levels as predictor of acute renal allograft rejection.
    Wang D, Wu GJ, Wu WZ, Yang SL, Chen JH, Wang H, Lin WH, Wang QH, Zeng ZX, Tan JM.
    Transpl Immunol; 2007 Jun 15; 17(4):278-82. PubMed ID: 17493531
    [Abstract] [Full Text] [Related]

  • 9. Pre-transplant soluble CD30 level as a predictor of not only acute rejection and graft loss but pneumonia in renal transplant recipients.
    Wang D, Wu WZ, Chen JH, Yang SL, Wang QH, Zeng ZX, Tan JM.
    Transpl Immunol; 2010 Feb 15; 22(3-4):115-20. PubMed ID: 20036333
    [Abstract] [Full Text] [Related]

  • 10. Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection.
    Slavcev A, Lácha J, Honsová E, Sajdlová H, Lodererová A, Vitko S, Skibová J, Striz I.
    Transpl Immunol; 2005 Jun 15; 14(2):117-21. PubMed ID: 15935302
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of pre- and posttransplantation serum interferon-gamma and soluble CD30 for predicting liver allograft rejection.
    Kim KH, Oh EJ, Jung ES, Park YJ, Choi JY, Kim DG, Lee KY, Kang CS.
    Transplant Proc; 2006 Jun 15; 38(5):1429-31. PubMed ID: 16797323
    [Abstract] [Full Text] [Related]

  • 12. Pretransplant soluble CD30 level has limited effect on acute rejection, but affects graft function in living donor kidney transplantation.
    Kim MS, Kim HJ, Kim SI, Ahn HJ, Ju MK, Kim HJ, Jeon KO, Kim YS.
    Transplantation; 2006 Dec 27; 82(12):1602-5. PubMed ID: 17198243
    [Abstract] [Full Text] [Related]

  • 13. Pretransplantation soluble CD30 level as a predictor of acute rejection in kidney transplantation: a meta-analysis.
    Chen Y, Tai Q, Hong S, Kong Y, Shang Y, Liang W, Guo Z, He X.
    Transplantation; 2012 Nov 15; 94(9):911-8. PubMed ID: 23052636
    [Abstract] [Full Text] [Related]

  • 14. Soluble CD30 levels in recipients undergoing heart transplantation do not predict post-transplant outcome.
    Ypsilantis E, Key T, Bradley JA, Morgan CH, Tsui S, Parameshwar J, Taylor CJ.
    J Heart Lung Transplant; 2009 Nov 15; 28(11):1206-10. PubMed ID: 19782609
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunological monitoring after organ transplantation: potential role of soluble CD30 blood level measurement.
    Truong DQ, Darwish AA, Gras J, Wieërs G, Cornet A, Robert A, Mourad M, Malaise J, de Ville de Goyet J, Reding R, Latinne D.
    Transpl Immunol; 2007 Jun 15; 17(4):283-7. PubMed ID: 17493532
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
    Solgi G, Furst D, Mytilineos J, Pourmand G, Amirzargar AA.
    Transpl Immunol; 2012 Mar 15; 26(2-3):81-7. PubMed ID: 22182633
    [Abstract] [Full Text] [Related]

  • 20. Value of soluble CD30 in liver transplantation.
    Fábrega E, Unzueta MG, Cobo M, Casafont F, Amado JA, Romero FP.
    Transplant Proc; 2007 Sep 15; 39(7):2295-6. PubMed ID: 17889168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.